Pharmas subleasing excess suburban space - Boston Business Journal:

doqujamup.wordpress.com
and are among companies that have listed space for sublease at their respectiveWaltham headquarters. Both companiee moved operations from the life science hub of Cambridgs to Walthamlast year. Altus is listing more than 150,000 square feet of office and lab sublease space at the Park in Earlier this year the biopharmaceuticalcompany (Nasdaq: ALTU) announced it wouled lay off 75 percent of its leaving 35 people at its Waltham according to published reports. ImmunoGen (Nasdaq: IMGN) is subleasing 14,00p0 square feet of the nearly 90,000 square feet of lab space it leases at 830Wintet St. in Waltham.
Immunogen plannexd to grow into excess space at 830 Winter but has decidec tosublease instead, sources said. This month ImmunoGen announced it would discontinue the internal development ofa gastric-cancer According to published reports, the company said the step will not have impact on its revenue, expenses or cash reserves. ImmunoGen booked $23.7 million in revenue and a net lossof $21. million during the nine months endedMarch 31.